Krishna Institute of Medical Sciences Limited (IN:KIMS)
:KIMS
Want to see IN:KIMS full AI Analyst Report?
KIMS Stock Chart & Stats
₹653.00
₹11.55(1.78%)
At close: 4:00 PM EST
₹653.00
₹11.55(1.78%)
Day’s Range― - ―
52-Week Range₹575.55 - ₹810.20
Previous CloseN/A
Volume1.26M
Average Volume (3M)23.04K
Market Cap
₹314.95B
Enterprise Value₹345.43B
Total Cash (Recent Filing)₹1.74B
Total Debt (Recent Filing)₹31.87B
Price to Earnings (P/E)130.4
Beta0.75
Next Earnings
Aug 12, 2026EPS Estimate
1.97Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.39
Shares Outstanding400,138,950
10 Day Avg. Volume26,167
30 Day Avg. Volume23,042
Financial Highlights & Ratios
PEG Ratio-2.77
Price to Book (P/B)11.07
Price to Sales (P/S)6.37
P/FCF Ratio-22.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11
Revenue Forecast (FY)₹51.22B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthConsistent multi-year revenue growth (about 3x from 2021–2026 and mid-teens growth in 2026) indicates expanding patient volumes and deeper market penetration. This durable top-line momentum supports scale economics, higher capacity utilization and the potential for margin recovery if cost controls follow.
Tertiary/quaternary Specialty NetworkA network focused on tertiary and quaternary care positions KIMS to capture higher‑acuity procedures and referral flows. Such clinical specialization creates durable differentiation, supports pricing for complex cases, and strengthens long‑term patient referrals and reputation versus generic, lower‑acuity competitors.
Diversified Hospital Revenue StreamsAn integrated mix of inpatient, outpatient, diagnostics, pharmacy and ancillary services reduces reliance on a single revenue source and increases patient lifetime value. This diversification enables cross‑sell, steadier utilization profiles and operational synergies that support sustainable earnings as volumes scale.
Bears Say
Sharply Rising LeverageDebt‑to‑equity rising to ~1.89 increases interest and refinancing exposure and reduces strategic flexibility. Heavy debt funding for expansion amplifies downside risk if earnings don’t scale as expected, limiting ability to absorb shocks or invest opportunistically over the medium term.
Deeply Negative Free Cash FlowPersistent negative free cash flow (~-11.15B in 2026) and OCF that only modestly exceeds net income indicate heavy capex/working capital needs and weak cash conversion. Reliance on external financing raises liquidity and execution risk, particularly given elevated debt levels and near‑term funding needs.
Margin DeteriorationMaterial compression in gross and net margins suggests cost pressure or weaker realizations and reduces return on invested capital. Lower margins constrain internal cash generation, making it harder to service higher debt, finance further expansion, or deliver sustainable shareholder returns without operational improvement.
Krishna Institute of Medical Sciences Limited News
KIMS FAQ
What was Krishna Institute of Medical Sciences Limited’s price range in the past 12 months?
Krishna Institute of Medical Sciences Limited lowest stock price was ₹575.55 and its highest was ₹810.20 in the past 12 months.
What is Krishna Institute of Medical Sciences Limited’s market cap?
Krishna Institute of Medical Sciences Limited’s market cap is ₹314.95B.
When is Krishna Institute of Medical Sciences Limited’s upcoming earnings report date?
Krishna Institute of Medical Sciences Limited’s upcoming earnings report date is Aug 12, 2026 which is in 58 days.
How were Krishna Institute of Medical Sciences Limited’s earnings last quarter?
Krishna Institute of Medical Sciences Limited released its earnings results on May 15, 2026. The company reported ₹1.215 earnings per share for the quarter, missing the consensus estimate of ₹1.528 by -₹0.313.
Is Krishna Institute of Medical Sciences Limited overvalued?
According to Wall Street analysts Krishna Institute of Medical Sciences Limited’s price is currently Overvalued.
Does Krishna Institute of Medical Sciences Limited pay dividends?
Krishna Institute of Medical Sciences Limited does not currently pay dividends.
What is Krishna Institute of Medical Sciences Limited’s EPS estimate?
Krishna Institute of Medical Sciences Limited’s EPS estimate is 1.97.
How many shares outstanding does Krishna Institute of Medical Sciences Limited have?
Krishna Institute of Medical Sciences Limited has 400,138,950 shares outstanding.
What happened to Krishna Institute of Medical Sciences Limited’s price movement after its last earnings report?
Krishna Institute of Medical Sciences Limited reported an EPS of ₹1.215 in its last earnings report, missing expectations of ₹1.528. Following the earnings report the stock price went down -1.767%.
Which hedge fund is a major shareholder of Krishna Institute of Medical Sciences Limited?
Currently, no hedge funds are holding shares in IN:KIMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited, known by its brand KIMS Hospitals across India, delivers a broad spectrum of medical and healthcare services. The institution boasts a comprehensive array of specialized fields, including cardiology, dentistry, neurology, oncology, orthopedics, nephrology, reproductive medicine, and robotic surgeries. Additionally, it offers expertise in gastroenterology, hepatology, heart and lung transplantation, general organ transplantation, maternal and pediatric care. Other key areas of focus include emergency and accident services, biochemistry, anesthesiology, bariatric surgery, andrology and infertility treatments, arthroscopy, Alzheimer's care, and dedicated bone and joint centers. Founded in 1973, the company is headquartered in Secunderabad, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―